Ajanta Pharma Limited
NSE: AJANTPHARM · Healthcare
₹3,554.90
-25.00 (-0.70%)
Last close · 30 Aug 2026, 11:55 am IST
- Open
- ₹3,580.00
- Day high
- ₹3,580.00
- Day low
- ₹3,500.70
- Volume
- 1.17 L
- Prev close
- ₹3,579.90
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty Midcap 150Nifty MidSmallcap 400Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 42,097 Cr
- Price
- 3,369.50
- P/E (TTM)
- 39.84
- P/E (Fwd)
- 29.60
- P/B
- 9.30
- EV/EBITDA
- 27.83
- EV/Revenue
- 7.65
- PEG
- —
- Div Yield
- 1.66%
- 52W High
- 3,598.80
- 52W Low
- 2,329.90
- Beta
- 0.18
Profitability & income
- Revenue (TTM)
- 5,453 Cr
- Net Income (TTM)
- 1,056 Cr
- EBITDA
- 1,498 Cr
- Gross Margin
- 78.29%
- Op. Margin
- 23.19%
- Net Margin
- 19.37%
- ROE
- 25.39%
- ROA
- 14.82%
- EPS (TTM)
- 84.57
- EPS (Fwd)
- 113.84
Financial health
- Total Debt
- 260 Cr
- Total Cash
- 665 Cr
- Debt/Equity
- 5.75
- Current Ratio
- 2.64
- Quick Ratio
- 1.78
- Book Value
- 362.41
- Free Cash Flow
- 1 Cr
- Op. Cash Flow
- 529 Cr
Growth
- Revenue Growth
- 21.50%
- Earnings Growth
- 18.60%
- Earnings QoQ
- 18.40%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,422 Cr | 267 Cr | 395 Cr | 731 Cr | 1,117 Cr | — | 260 Cr | 4,527 Cr |
| 2025-12-31 | 1,375 Cr | 274 Cr | 407 Cr | 715 Cr | 1,089 Cr | — | — | — |
| 2025-06-30 | 1,303 Cr | 255 Cr | 378 Cr | 683 Cr | 1,027 Cr | — | — | — |
| 2025-03-31 | 1,170 Cr | 225 Cr | 315 Cr | 567 Cr | 887 Cr | — | 47 Cr | 3,790 Cr |
| 2024-12-31 | 1,146 Cr | 233 Cr | 351 Cr | 587 Cr | 888 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 5,407 Cr | 1,056 Cr | 1,567 Cr | 1,327 Cr | 4,160 Cr | 529 Cr | 260 Cr | 4,527 Cr |
| 2025-03-31 | 4,588 Cr | 920 Cr | 1,354 Cr | 1,128 Cr | 3,460 Cr | 1,157 Cr | 47 Cr | 3,790 Cr |
| 2024-03-31 | 4,162 Cr | 816 Cr | 1,257 Cr | 1,046 Cr | 3,046 Cr | 785 Cr | 35 Cr | 3,567 Cr |
| 2023-03-31 | 3,708 Cr | 588 Cr | 882 Cr | 680 Cr | 2,591 Cr | 792 Cr | 36 Cr | 3,388 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for AJANTPHARM?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in